¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lead nephropathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® lead poisoning, saturinism ÇÑ±Û ³³Áßµ¶
¼³¸í   
  ¿ëÇØ¼º ³³À» ÈíÀÔÇϰųª »ïÅ´À¸·Î½á À¯¹ßµÇ´Â Á÷¾÷º´. ±Þ¼º°ú ¸¸¼ºÀÌ ÀÖÀ¸¸ç ´ë·®À¸·Î Èí¼öÇÏ¿© ±Þ¼º À§Àå¿° Áõ»óÀ» ³ªÅ¸³»´Â ±Þ¼º Áßµ¶Àº ¿ÀÈ÷·Á µå¹°°í, ±Ø¼Ò·®(1ÀÏ 1mg ÀÌÇÏ)ÀÇ ³³À» Àå±â°£ Áö¼ÓÀûÀ¸·Î ¼·ÃëÇÔÀ¸·Î½á »ý±â´Â ¸¸¼ºÀÌ ´õ ½É°¢ÇÏ´Ù. ³³Á¦·Ã¾÷-ȰÆÇÀμâ¾÷-µµÀå¾÷-³³À¯¸®Á¦Á¶¾÷-ÃàÀüÁöÁ¦Á¶¾÷ µî ³³ ¶Ç´Â ³³À» ÇÔÀ¯ÇÑ ¹°ÁúÀ» ´Ù·ç´Â »ç¶÷, ¶Ç °ú°Å¿¡´Â ¿¬¹éÀ» »ç¿ëÇÑ ºÐ¿¡ ÀÇÇÑ È­Àåµ¶ÀÌ ¿©¼º¿¡°Ô ³ªÅ¸³ª ¹®Á¦°¡ µÇ¾úÀ¸³ª, ¿À´Ã³¯¿¡´Â °¡¼Ö¸°¿¡ È¥ÇյȠ¾ÈƼ³ìÁ¦ÀΠ»ç¿¡Æ¿³³À¸·Î ÀÎÇÑ Áßµ¶ÀÌ ÁÖ¸ñµÇ°í ÀÖ´Ù. »ç¿¡Æ¿³³ Áßµ¶ÀÇ Áõ»óÀº ¿©·¯ °¡ÁöÀε¥, ºóÇ÷À̳ª ¶³¸®´Â Áõ»óÀÌ ºñ±³Àû Ãʱ⿡ ³ªÅ¸³ª°í ³³¼±(ÀÕ¸ö¿¡ ³³ÀÌ Ä§ÂøÇÏ¿© Ã»È¸¹é»öÀ¸·Î Âø»öµÈ´Ù)À̳ª ¹ßÀÛÀû º¹ÅëÀ̠Ư¡ÀÌ´Ù. ÀϹÝÀûÀ¸·Î ³³ÀÇ Áõ±â³ª °¡·ç°¡ ±âµµ¸¦ ÅëÇØ Ã¼³»·Î µé¾î°¡´Â °æ¿ì°¡ µµ·á-¾È·á¿¡ µé¾î Àִ ³³ÀÌ ÇǺγª ¼ÒÈ­°üÀ» ÅëÇØ Ä§ÅõÇϴ Áõ·Êº¸´Ù Áõ»óÀÌ ½ÉÇÏ´Ù.
¿µ¹® diabetic nephropathy ÇÑ±Û ´ç´¢º´ÄáÆÏº´Áõ
¼³¸í   
  ¿À·¡µÈ ´ç´¢ÀÇ ÇÕº´ÁõÀ¸·Î ¹ß»ýÇÑ´Ù. ´ë°³ ´ç´¢º´¿¡ ÀÌȯµÈ °æ¿ì ´ç´¢º´ ÀÚü¿¡ ÀÇÇÑ Áúº´º¸´Ù ¿À·£ ±â°£ÈÄÀÇ ÇÕº´Áõ¿¡ ÀÇÇØ ¸ñ¼ûÀ» ÀҴ °æ¿ì°¡ ¸¹´Ù. Ãʱ⿡ ´ç´¢º´¿¡¼­ Ç÷Áß Æ÷µµ´ç³óµµ¸¦ Àß Á¶ÀýÇÑ °æ¿ì ÀÌ·± ÇÕº´ÁõÀÌ ¹ß»ýÇϴ °æ¿ì°¡ ³·À¸³ª, ±×·¸Áö ¸øÇÑ °æ¿ì ½ÅÀåÀÇ ÇÕº´ÁõÀÌ ¹ß»ýÇÒ ¼ö ÀÖ´Ù. Çѹø ¹ß»ýÇÑ °æ¿ì, Ä¡·á´Â ºÒ°¡´ÉÇϸç, ±× ÁøÇà ¶ÇÇÑ ´ÊÃâ ¼ö ¾ø´Ù. Ä¡·á¹ýÀº ¿ÀÁ÷ Çϳª ÄáÆÏÀ̽ļú¿¡ ÀÇÇØ¼­¸¸ °¡´ÉÇϸç À̽ļúÀ» ½ÃÇàÇÑ ÀÌÈÄ¿¡µµ Ç÷´ç·®ÀÇ Á¶ÀýÀº ÇʼöÀûÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • analgesic nephropathy
    ÁøÅëÁ¦ÄáÆÏº´(Áõ), ÁøÅëÁ¦½ÅÀ庴(Áõ)
  • diabetic nephropathy
    ´ç´¢ÄáÆÏº´(Áõ), ´ç´¢½ÅÀ庴(Áõ)
  • gouty nephropathy
    ÅëdzÄáÆÏº´(Áõ), Åëdz½ÅÀ庴(Áõ)
  • hyperuricemic nephropathy
    °í¿ä»êÇ÷ÁõÄáÆÏº´(Áõ), °í¿ä»êÇ÷Áõ½ÅÀ庴(Áõ)
  • IgA nephropathy
    IgAÄáÆÏº´(Áõ), IgA½ÅÀ庴(Áõ)
  • light-chain nephropathy
    °¡º­¿î»ç½½ÄáÆÏº´(Áõ), °æ¼â½ÅÀ庴(Áõ)
  • membranous nephropathy
    ¸·¼ºÄáÆÏº´(Áõ), ¸·¼º½ÅÀ庴(Áõ)
  • nephropathy
    ÄáÆÏº´(Áõ), ½ÅÀ庴(Áõ)
  • obstructive nephropathy
    ¸·ÈûÄáÆÏº´(Áõ), Æó¼â½ÅÀ庴(Áõ)
  • reflux nephropathy
    ¿ª·ùÄáÆÏº´(Áõ), ¿ª·ù½ÅÀ庴(Áõ)
  • urate nephropathy
    ¿ä»ê¿°ÄáÆÏº´(Áõ), ¿ä»ê¿°½ÅÀ庴(Áõ)
  • uric acid nephropathy
    ¿ä»ê¿°ÄáÆÏº´(Áõ), ¿ä»ê¿°½ÅÀ庴(Áõ)
  • bipolar lead
    µÎ±ØÀ¯µµ, ½Ö±ØÀ¯µµ
  • black lead
    Èæ¿¬
  • electrocardiogram lead
    ½ÉÀüµµÀ¯µµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lead
    1. ³³, 2. µµÃâ, À¯µµ
  • air lead
    °ø±â´©Ãâ
  • lead poisoning
    ³³Áßµ¶
  • nephropathy
    ÄáÆÏº´Áõ, ½ÅÀ庴Áõ
  • IgA nephropathy
    ¸é¿ª±Û·Îºí¸°¿¡ÀÌÄáÆÏº´Áõ, ¸é¿ª±Û·Îºí¸°¿¡À̽ÅÀ庴Áõ
  • diabetic nephropathy
    ´ç´¢º´ÄáÆÏº´Áõ
  • membranous nephropathy
    ¸·¼ºÄáÆÏº´Áõ
  • urate nephropathy
    ¿ä»ê¿°ÄáÆÏº´Áõ
  • uric acid nephropathy
    (¢¡ urate nephropathy) ¿ä»ê¿°ÄáÆÏº´Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • analgesic nephropathy
    ÁøÅëÁ¦ÄáÆÏº´Áõ
  • diabetic nephropathy
    ´ç´¢º´ÄáÆÏº´Áõ
  • gouty nephropathy
    ÅëdzÄáÆÏº´Áõ
  • hyperuricemic nephropathy
    °í´¢»êÇ÷ÁõÄáÆÏº´Áõ
  • light-chain nephropathy
    °¡º­¿î»ç½½ÄáÆÏº´Áõ
  • membranous nephropathy
    (¢¡glomerulonephritis) Å丮ÄáÆÏ¿°, »ç±¸Ã¼½Å¿°
  • nephropathy
    ÄáÆÏº´Áõ, ½ÅÀ庴Áõ
  • obstructive nephropathy
    ¸·ÈûÄáÆÏº´Áõ
  • reflux nephropathy
    ¿ª·ùÄáÆÏº´Áõ
  • toxic nephropathy
    µ¶¼ÒÄáÆÏº´Áõ
  • tropical nephropathy
    ¿­´ëÄáÆÏº´Áõ
  • urate nephropathy
    ¿ä»ê¿°ÄáÆÏº´Áõ
  • uric acid nephropathy
    (¢¡urate nephropathy) ¿ä»ê¿°ÄáÆÏº´Áõ
  • black lead
    Èæ¿¬
  • lead-time bias
    Á¶±â¹ß°ß±â°£¹ÙÀ̾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • plumbism =lead poisoning
    ³³Áßµ¶(ÊÙÌ¡ËÄ).
  • plumbism =lead poisoning
    ³³Áßµ¶(¡­ñéÔ¸)
  • plumbism =lead poisoning
    ³³Áßµ¶(¡­ñéÔ¸).
  • red lead
    ¿¬´Ü(æçÕ®).
  • Balkan nephropathy
    ¹ßÄ­ ½Åº´Áõ
  • analgesic nephropathy
    ÁøÅëÁ¦Àμº ½Åº´Áõ
  • gouty nephropathy
    Åëdz¼º ½Åº´Áõ
  • hyperuricemic nephropathy
    °í¿ä»êÇ÷Áõ¼º ½Åº´Áõ.
  • hyperuricemic nephropathy
    °í´¢»êÇ÷Áõ¼º ½Åº´Áõ.
  • immunoglobulin a nephropathy
    ¸é¿ª±Û·ÎºÒ¸°A½Åº´Áõ(Øó湡­ãìÜ»ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chest lead = precordial lead
    ÈäºÎÀ¯µµ(ýØÝ»ë¯Óô)
  • analgesic nephropathy
    ÁøÅëÁ¦Àμº ½Åº´Áõ
  • balkan nephropathy
    ¹ßÄ­ ½ÅÁõ(¡­ãìñø)
  • diabetic nephropathy
    ´ç´¢º´(¼º) ½Åº´Áõ.
  • diabetic nephropathy
    ´ç´¢º´¼º ½Åº´Áõ(¡­ãìÜ»ñø)
  • gouty nephropathy
    Åëdz¼º ½Åº´Áõ
  • hyperuricemic nephropathy
    °í¿ä»êÇ÷Áõ¼º ½Åº´Áõ.
  • hyperuricemic nephropathy
    °í´¢»êÇ÷Áõ¼º ½Åº´Áõ.
  • hypokalemic nephropathy
    ÀúÄ®·ý¼º ½Åº´Áõ.
  • hypokalemic nephropathy
    ÀúÄ®·ýÇ÷¼º ½Åº´Áõ
  • immunoglobulin a nephropathy
    ¸é¿ª±Û·ÎºÒ¸°A½Åº´Áõ(Øó湡­ãìÜ»ñø)
  • light-chain nephropathy
    °æ¼â ½ÅÁõ(Ìã ãìñø)
  • membranous nephropathy
    ¸·¼º½Åº´Áõ(¡­ãìÜ»ñø)
  • nephropathy
    ½Åº´Áõ,(¡­Ü»ñø), ½ÅÁõ(¡­ñø)
  • obstructive nephropathy
    Æó¼â¼º ½ÅÁúȯ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lead
    ³³(æç)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephropathy
    ½Åº´Áõ, ½ÅÁõ
  • lead
    ³³, ¿¬, À¯µµ, ºÐ±Ø
  • lead encephalopathy
    ¿¬³úÁõ
  • lead glass
    ³³À¯¸®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
AAN AIDS-associated nephropathy; alpha-amino nitrogen; American Academy of Neurology; American Academy o...
AVR Augmented Voltage Right arm
  Frank N. Wilson
  Lead I, II, III¿Í °°Àº Å©±âÀÇ E...
MGN Membranous Glomerulo-Nephritis(Nephropathy)
MN   1) Membranous Nephropathy
  2) Mid-Night; ÀÚÁ¤
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ABLES Adult Blood Lead Epidemiology and Surveillance program
BLL Blood lead level
LEAD Lower extremity arterial disease
TEL Tetraethyl lead
AN Analgesic nephropathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • analgesic nephropathy
    ÁøÅëÁ¦Àμº ½Åº´Áõ
  • balkan nephropathy
    ¹ßÄ­ ½ÅÁõ
  • nephropathy
    ½Åº´Áõ, ½ÅÁõ, ½ÅÀ庴Áõ
    ½ÅÀå¿¡ »ý±ä Áúº´.
  • obstructive nephropathy
    Æó¼â¼º ½Å Áúȯ
  • augmented limb lead
    ÁõÆø »çÁö À¯µµ
  • bipolar extremity lead
    ½Ö±ØÁö À¯µµ
  • endocardial lead
    ½É³»¸· À¯µµ
  • lead acetate
    ÃÊ»ê ³³
  • lead anemia
    ¿¬ ºóÇ÷
    ³³¿¡ ÀÇÇÏ¿© ¹ß»ýÇÏ´Â ºóÇ÷.
  • lead borosilicate
    ºØ±Ô»ê ³³
  • lead chromate
    Å©·Ò»ê ³³
  • lead dichloride
    ÀÌ¿°È­ ³³
  • lead equivalent
    ¿¬ ´ç·®
    ¹æ»ç¼± Â÷Æó¿¡ À־ ¾î¶² ¹°ÁúÀÇ Â÷Æó È¿°ú¸¦ ±×¿Í ºñ½ÁÇÑ È¿°ú¸¦ ³ªÅ¸³»´Â ³³ÀÇ µÎ²²·Î Ç¥ÇöÇÑ °Í.
  • lead glass
    ³³ À¯¸®
    X¼± ÃÔ¿µ ½Ã 1Â÷¼±À̳ª 2Â÷¼±À¸·ÎºÎÅÍ º¸È£¹Þ±â À§ÇÏ¿© ¹æ¾î¸· ¶Ç´Â ¹æ¾îº®ÀÇ Ã¢¹®¿¡ ÀåÄ¡ÇÏ´Â À¯¸®·Î, ±× ¾È¿¡ ³³ÀÌ µé¾î ÀÖ´Â °Í.
  • lead gray
    ³³ ȸ»ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
aids-associated nephropathy Renal syndrome in human immunodeficiency virus-infected patients characterised by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients.
(12 Dec 1998)
analgesic nephropathy <nephrology, pathology> A form of kidney damage which can occur from the overexposure to certain analgesics (for example acetaminophen, salicylates and non-steroidal anti-inflammatory agents).
In most cases analgesic use is excessive in dosing or chronicity of use. Complications include acute renal failure.
See: interstitial nephritis.
Origin: Gr. Pathos = disease
(27 Sep 1997)
balkan nephropathy A tubulointerstitial disease of unknown aetiology occurring in a limited geographic area including adjacent regions of romania, bulgaria, and yugoslavia.
(12 Dec 1998)
reflux nephropathy <nephrology> A condition where the chronic backup of urine into a kidney results in kidney damage. Urine is forced out of the bladder and back toward kidney. This condition occurs most commonly in children who have congenital abnormalities of the urinary tract.
Symptoms include back pain, flank, pain, abdominal pain, urinary frequency or urgency and blood in the urine. Other symptoms include nausea, fever and chills, most often indicating a kidney infection has occurred.
Diagnosis is frequently confirmed by voiding cystourethrogram. Surgery is often required to correct the reflux of urine.
Origin: Gr. Pathos = disease
(27 Sep 1997)
membranous nephropathy <pathology> A kidney disease that occurs due to inflammation of the kidney glomerulus and its basement membrane.
The exact cause is unknown but it appears to be related to the deposition of immune complexes in the basement membrane leading to thickening of the capillary walls. This disorder is a common cause of nephrotic syndrome an is usually how the disease manifests.
Risk factors include primary renal disease, malaria, hepatitis B, lupus, syphilis, cancers and non-Hodgkin's lymphomas. Risks also include exposure to some medications such as gold compounds and penicillamine. Mercury, trimethadione and some skin-lightening creams have also been implicated.
Treatment includes systemic corticosteroids and immunosuppressive agents.
(26 Mar 1998)
hereditary deafness and nephropathy <nephrology, pathology> An inherited disorder involving damage to the kidneys, haematuria and hearing loss. In some individuals vision may also be affected. This genetic disease is uncommon.
Symptoms include loss of hearing, abnormal colour to urine, swelling, cough and decline in vision.
Inheritance: sex-linked autosomal dominant.
Incidence: 1 in 50,000.
Origin: Gr. Pathos = disease
(27 Sep 1997)
hypokalaemic nephropathy Vacuolation of the epithelial cytoplasm of renal convoluted tubules in patients seriously depleted of potassium; vacuoles do not contain fat or glycogen, concentrating ability is impaired, polyuria and polydipsia are common, and pyelonephritis may develop.
Synonym: vacuolar nephrosis.
(05 Mar 2000)
nephropathy <nephrology, urology> Any disease of the kidneys.
Origin: Gr. Pathos = disease
(18 Nov 1997)
Danubian endemic familial nephropathy A tubulointerstitial disease of unknown aetiology occurring in a limited geographic area including adjacent regions of romania, bulgaria, and yugoslavia.
(12 Dec 1998)
diabetic nephropathy <nephrology, pathology> Kidney disease and resultant kidney function impairment due to the long standing effects of diabetes on the microvasculature (glomerulus) of the kidney. Features include increased urine protein and declining kidney function.
Severe diabetic nephropathy can lead to kidney failure and end-stage renal disease.
Origin: Gr. Pathos = disease
(27 Sep 1997)
IgA nephropathy <nephrology, pathology> This is a form of glomerulonephritis that results from the deposition of circulating IgA antibody in the kidney tissues.
Inflammation of the glomerulus (glomerulonephritis) is the result. This condition may present as acute glomerulonephritis, chronic glomerulonephritis or rapidly progressive glomerulonephritis.
Berger's is usually detected in an individual with one or two bouts of bloody urine (usually begins during or soon after a respiratory infection) and no other symptoms of renal disease. Only rarely, will Berger's disease permanently affect kidney function and progress to chronic renal failure. This renal disorder more commonly affects males in the 16-40 age group.
Origin: Gr. Pathos = disease
(27 Sep 1997)
IgM nephropathy <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome.
Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine.
Acronym: MPGN
(05 Jan 1998)
augmented lead Electrocardiogram recorded between one limb and two other limbs. The augmented lead are designated aVF, aVL, and aVR for recordings made between the foot (left), left arm, and right arm, respectively, and the other two limbs.
(05 Mar 2000)
bipolar lead A record obtained with two electrodes placed on different regions of the body, each electrode contributing significantly to the record; e.g., a standard limb lead.
(05 Mar 2000)
black lead Plumbago; graphite.It leaves a blackish mark somewhat like lead. See Graphite.
Source: Websters Dictionary
(01 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephropathy
    (º´¸®)½ÅÀåÇØ;½ÅÁß;½ÅÀ庴
  • lead
    1|À̲ø´Ù,ÁöµµÇÏ´Ù,²ø´Ù,º¸³»´Ù,¿ì¼¼ 2|³³,³¬½ËºÀ,ź¾Ë
  • lead to
    -À¸·Î À̸£´Ù
  • black lead
    Èæ¿¬
  • dog lead
    °³ÁÙ;°³»ç½½
  • friendly lead
    (Áö¿ª °øµ¿ »ç¾÷ÀÇ) °øÁ¦ ÀÚ±Ý ¸ðÁýÀ» À§ÇÑ À§¾Èȸ
  • lead
    ³³;³³Á¦Ç°;(¿¬ÇÊÀÇ) ½É;Ãø¿¬;ÇÔ¼® ÁöºØ;heave the ~ ¼ö½ÉÀ» Àç´Ù
  • lead
    ¼±µµ;¼Ö¼±;ÁöÈÖ;Áöħ;Á¶¾ð;¿ì¼¼;(¹°À» ²ø¾îµéÀÌ´Â) µµ·®;µµ¼±;±¤¸Æ;follow the ~ of ...ÀÇ ¿¹¿¡ µû¸£´Ù
  • lead
    ¾È³»ÇÏ´Ù;(±æÀÌ) ÅëÇÏ´Ù;¼Ö¼±ÇÏ´Ù;~ away µ¥¸®°í °¡´Ù;~ by the nose ¸ÍÁ¾½ÃŰ´Ù;~ off ½ÃÀÛÇÏ´Ù;~ on ²Ò´Ù
  • lead
    ³³À» ¾º¿ì´Ù(ä¿ö ¸Å¿ì´Ù);Àε¥¸£¸¦ ä¿ì´Ù
  • lead
    Àεµ(¾È³»)ÇÏ´Ù;°Å´À¸®´Ù;²Ò´Ù;Áö³»´Ù;(»ýȰ,ÀÏ»óÀ») º¸³»´Ù
  • lead nitrate
    Áú»ê¿°
  • lead oxide
    »êÈ­¿¬
  • lead pencil
    (Èæ½ÉÀÇ º¸Åë) ¿¬ÇÊ
  • lead poisoning
    ³³Áßµ¶;¿¬µ¶
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á